Join us for an insightful webinar, led by Dr. Peter Florian, exploring the vital role of Pharmacokinetics (PK) and Pharmacodynamics (PD) in driving Drug-development within the pharmaceutical industry.
Whether you're a seasoned researcher or new to the field, this webinar promises to provide valuable insights into the intersection of PK/PD and drug development in the pharmaceutical landscape.
In this webinar you will learn about:
• Fundamentals of Pharmacokinetics and Pharmacodynamics
• Importance of PK/PD in Drug Development in industry
• Case Studies Highlighting PK/PD Applications
Peter is a seasoned expert in the realm of pharmacokinetic and pharmacodynamic-driven drug discovery, boasting over two decades of rich experience in the industry. Having honed his skills at pharmaceutical giants like Pfizer and Sanofi, Peter currently serves as Head of Non-infectious Disease Research at Boehringer Ingelheim.
The Webinar will be hosted by SPARK FLI.
Online via Zoom | Please register here!
Registration to the webinar is required in advance. Please register no later than (June 4th). Please note that you will receive the meeting link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
